Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spyre Therapeutics, Inc. has filed 781 SEC EDGAR filings since 24 Mar 2015

SEC filing history

Showing 576-600 of 781 matching filings.

Per page
25
Current page
24
UPLOAD

UPLOAD filing

Filing date
04 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89456

SC 13G/A filing

Filing date
31 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89456

13G AMENDED ANNUAL FILING - AGLE

Filing date
31 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-228967

S-3

Filing date
21 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
21 Dec 2018
Reporting date
17 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
11 Dec 2018
Reporting date
11 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
11 Dec 2018
Reporting date
11 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Dec 2018
Reporting date
07 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
29 Nov 2018
Reporting date
26 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
08 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
22 Oct 2018
Reporting date
21 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
17 Oct 2018
Reporting date
17 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89456

AEGLEA BIOTHERAPEUTICS, INC.

Filing date
11 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
10 Oct 2018
Reporting date
08 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Sep 2018
Reporting date
27 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37722

DEF 14A

Filing date
06 Sep 2018
Reporting date
08 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
04 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Aug 2018
Reporting date
17 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Aug 2018
Reporting date
13 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
09 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
23 Jul 2018
Reporting date
18 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Jul 2018
Reporting date
18 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .